UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Increased survival and reversion of iron-induced cardiac disease in patients with thalassemia major receiving intensive combined chelation therapy as compared to desferoxamine alone

Blood cells, molecules, & diseases, 2010-08, Vol.45 (2), p.136-139

2010

Volltextzugriff (PDF)

Deferasirox (ICL670A) effectively inhibits oesophageal cancer growth in vitro and in vivo

British journal of pharmacology, 2013-03, Vol.168 (6), p.1316-1328

2013

Volltextzugriff (PDF)

Iron chelation destabilizes bacterial biofilms and potentiates the antimicrobial activity of antibiotics against coagulase-negative Staphylococci

Pathogens and disease, 2018-07, Vol.76 (5)

2018

Volltextzugriff (PDF)

Is aceruloplasminemia treatable? Combining iron chelation and fresh-frozen plasma treatment

Neurological sciences, 2017-02, Vol.38 (2), p.357-360

2017

Volltextzugriff (PDF)

Combined iron chelation therapy

Annals of the New York Academy of Sciences, 2010-08, Vol.1202 (1), p.79-86

2010

Volltextzugriff (PDF)

Therapeutic mechanism of combined oral chelation therapy to maximize efficacy of iron removal in transfusion-dependent thalassemia major - a pilot study

Expert review of hematology, 2019-04, Vol.12 (4), p.265-272

2019

Volltextzugriff (PDF)

Low oxygen tension reverses antineoplastic effect of iron chelator deferasirox in human glioblastoma cells

BMC cancer, 2016-02, Vol.16 (51), p.51-51, Article 51

2016

Volltextzugriff (PDF)

Transfusion Independency and Histological Remission in a Patient with Advanced Primary Myelofibrosis Receiving Iron-Chelation Therapy with Deferasirox

Oncology research and treatment, 2016-06, Vol.39 (6), p.384-387

2016

Volltextzugriff (PDF)

Transfusions in myelodysplastic syndromes

Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine, 2017-09, Vol.24 (3), p.209

Rose, C

2017

Volltextzugriff (PDF)

Iron overload during follow-up after tandem high-dose chemotherapy and autologous stem cell transplantation in patients with high-risk neuroblastoma

Journal of Korean Medical Science, 2012, 27(4), 162, pp.363-369

2012

Volltextzugriff (PDF)

Therapeutic Modalities for Patients with Lower-Risk Myelodysplastic Syndromes: Current Options and Future Directions

Current hematologic malignancy reports, 2011-03, Vol.6 (1), p.5-12

2011

Volltextzugriff (PDF)

Comparison of Oral and Subcutaneous Iron Chelation Therapies in the Prevention of Major Endocrinopathies in β-Thalassemia Major Patients

Hemoglobin, 2006-01, Vol.30 (2), p.257-262

2006

Volltextzugriff (PDF)

Pilot Study on the "Quality of Life" as Reflected by Psychosocial Adjustment of Children with Thalassemia Major Undergoing Iron-Chelating Treatment in Western Taiwan

Hemoglobin, 2006, Vol.30 (2), p.291-299

2006

Volltextzugriff (PDF)

Pilot Study on Parental Stress and Behavioral Adjustment to the Thalassemia Major Disease Process in Children Undergoing Iron-Chelation in Western Taiwan

Hemoglobin, 2006-01, Vol.30 (2), p.301-309

2006

Volltextzugriff (PDF)

Superficial hemosiderosis of the central nervous system

Movement disorders, 1994, Vol.9 (5), p.559-562

1994

Volltextzugriff (PDF)

High incidence of cardiomyopathy in beta-thalassaemia patients receiving regular transfusion and iron chelation: reversal by intensified chelation

Acta haematologica, 1990, Vol.84 (3), p.113-117

1990

Volltextzugriff (PDF)

1 – 16 von 16

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(16)
Mit Volltextzugriff
(13)

Publikationsform

Artikel
(16)

Sprache

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Increased survival and reversion of iron-induced cardiac disease in patients with thalassemia major receiving intensive combined chelation therapy as compared to desferoxamine alone

Deferasirox (ICL670A) effectively inhibits oesophageal cancer growth in vitro and in vivo

Iron chelation destabilizes bacterial biofilms and potentiates the antimicrobial activity of antibiotics against coagulase-negative Staphylococci

Is aceruloplasminemia treatable? Combining iron chelation and fresh-frozen plasma treatment

Combined iron chelation therapy

Therapeutic mechanism of combined oral chelation therapy to maximize efficacy of iron removal in transfusion-dependent thalassemia major - a pilot study

Low oxygen tension reverses antineoplastic effect of iron chelator deferasirox in human glioblastoma cells

Transfusion Independency and Histological Remission in a Patient with Advanced Primary Myelofibrosis Receiving Iron-Chelation Therapy with Deferasirox

Transfusions in myelodysplastic syndromes

Iron overload during follow-up after tandem high-dose chemotherapy and autologous stem cell transplantation in patients with high-risk neuroblastoma

Therapeutic Modalities for Patients with Lower-Risk Myelodysplastic Syndromes: Current Options and Future Directions

Comparison of Oral and Subcutaneous Iron Chelation Therapies in the Prevention of Major Endocrinopathies in β-Thalassemia Major Patients

Pilot Study on the "Quality of Life" as Reflected by Psychosocial Adjustment of Children with Thalassemia Major Undergoing Iron-Chelating Treatment in Western Taiwan

Pilot Study on Parental Stress and Behavioral Adjustment to the Thalassemia Major Disease Process in Children Undergoing Iron-Chelation in Western Taiwan

Superficial hemosiderosis of the central nervous system

High incidence of cardiomyopathy in beta-thalassaemia patients receiving regular transfusion and iron chelation: reversal by intensified chelation

Suchergebnisse filtern